Approval
(1) Approval or re-approval. If CMS approves or re-approves the home infusion therapy accrediting organization's home infusion therapy accreditation program, the final notice at a minimum includes the following information: (i) A description of how the home infusion therapy accreditation program meets or exceeds Medicare home infusion therapy accreditation program requirements. (ii) The effective date of approval (no later than the publication date of the notice). (iii) The term of the approval (6 years or less). (2) Denial. If CMS does not approve the home infusion therapy accrediting organization's accreditation program, the final notice describes the following: (i) How the home infusion therapy accrediting organization fails to meet Medicare home infusion therapy accreditation program requirements. (ii) The effective date of the decision.